Skip to main content
LUCD
NASDAQ Industrial Applications And Services

Lucid Diagnostics Q2 2026: Revenue Climbs 27% and First LBM Coverage Policy Secured

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.971
Mkt Cap
$199.899M
52W Low
$0.861
52W High
$1.629
52W Position info
13% above low
Off High info
40% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LUCD is trading near its 52-week low of $0.861 (13% above the low).

Summary

Q2 2026 revenue rose 27% year-over-year to $1.5 million, and the first LBM coverage policy for EsoGuard was secured. Going concern doubt was reiterated, with a debt waiver expiring August 22.


Key Events · Earnings and Guidance · LUCD

  • Q2 Revenue Up 27%

    EsoGuard revenue for Q2 2026 was $1.5 million, up from $1.2 million in Q2 2025, with 2,770 tests processed.

  • First LBM Coverage Policy

    A commercial coverage policy was secured from Concert, a healthcare technology company recently acquired by Lyric, which recognizes EsoGuard as medically necessary and has been adopted by multiple client health plans.

  • Cost-Effectiveness Model

    A health economic model was developed showing improved clinical outcomes and cost-effectiveness for EsoGuard screening, supporting payor engagement.

  • Cash Position

    Cash and cash equivalents were $33.4 million as of June 30, 2026, down from $34.7 million at year-end 2025.


Analysis · LUCD · Industrial Applications And Services

Revenue for Q2 2026 reached $1.5 million, a 27% year-over-year increase, with 2,770 EsoGuard tests processed. A first laboratory benefit manager (LBM) coverage policy was secured from Concert, which could accelerate commercial adoption. Yet significant financial challenges persist: a GAAP net loss of $14.7 million, a going concern warning, and a key debt waiver expiring August 22. The new coverage policy and cost-effectiveness model are positive developments, but near-term liquidity risk remains critical.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LUCD was trading at $0.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $199.9M. The 52-week trading range was $0.86 to $1.63. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LUCD - Latest Insights

LUCD
Nov 12, 2026, 8:11 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.4212
Real-time Price: $0.42795 info
Change: +$0.00675 (+2%) info
Market Cap: $88.576M info
LUCD
Nov 12, 2026, 8:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4212
Real-time Price: $0.42795 info
Change: +$0.00675 (+2%) info
Market Cap: $88.576M info
LUCD
Nov 12, 2026, 8:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.4212
Real-time Price: $0.42795 info
Change: +$0.00675 (+2%) info
Market Cap: $88.576M info
LUCD
Oct 22, 2026, 6:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.5152
Real-time Price: $0.42795 info
Change: -$0.08725 (-17%) info
Market Cap: $88.576M info
LUCD
Oct 22, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3584
Real-time Price: $0.42795 info
Change: +$0.06955 (+19%) info
Market Cap: $88.576M info